Cardiovascular Institute, Goteborg

Hormone replacement therapy reduces left ventricular mass

Published in Hospital Business Week, June 12th, 2005

Oral hormone replacement therapy (HRT) seems to have a beneficial impact on cardiovascular health in hypertensive postmenopausal women, researchers reported on May 14, 2005, at the American Society of Hypertension 20th Annual Meeting held in San Francisco.

"Hormone replacement therapy, often used by women for postmenopausal symptom relief, has gained significant attention recently for studies suggesting an association with cardiovascular risk," said Karin Manhem, MD, from the Cardiovascular Institute in Goteborg, Sweden. "Our study seems to suggest a cardiovascular benefit associated with HRT treatment over 6 months."

Left ventricular hypertrophy...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Business Week

Source: Hospital Business Week (2005-06-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry